$BABY (Natus Medical Inc.)

$BABY {{ '2016-03-04T14:38:02+0000' | timeago}} • Announcement

Healthcare products company $BABY said it has acquired the assets of NeuroQuest, LLC, a provider of neurodiagnostic services, thereby expanding its neurodiagnostic services into seven new states. The company expects this acquisition to add approx. $2.5MM in additional revenue during 2016 and to be immediately accretive to earnings.

$MDT {{ '2018-01-16T17:16:57+0000' | timeago}} • Announcement

$MDT received FDA clearance of the Riptide Aspiration System, adding a valuable tool to the Acute Ischemic Stroke (AIS) product portfolio. This is designed to retrieve thrombus (or blood clot) through the Arc Catheter and restore blood flow in patients experiencing blockage of an artery in the brain, known as an ischemic stroke.

$MDT {{ '2018-01-10T14:44:35+0000' | timeago}} • Announcement

The FDA has approved an innovative clinician programmer for the SynchroMed-II Intrathecal Drug Delivery system developed by medical technology company $MDT, for chronic pain and spasticity. SynchroMed-II, an implantable pump, delivers medication directly to the fluid around the spinal cord. It is an app that facilitates simple, guided workflows.

$SYK {{ '2018-01-09T17:21:37+0000' | timeago}} • Announcement

$SYK said that for 4Q17 its preliminary results are of net sales growth of 10% to $3.5Bil, while for FY17, its net sales grew 9.9% to $12.4Bil. Excluding the impact of foreign currency & acquisitions, net sales rose 8.1% and 7.1% in 4Q17 and FY17. For 2018, $SYK expects modest headwinds that will be manageable within its overall financial targets.

$HRC {{ '2018-01-09T17:07:14+0000' | timeago}} • Announcement

$HRC announced its preliminary 1Q18 revenue. For this period, the company expects worldwide revenue of approx $670MM, an increase of 5% YoY. Core revenue increased approx 2%, exceeding the company's previously issued guidance of flat core revenue growth.

$BABY {{ '2018-01-08T12:48:13+0000' | timeago}} • Announcement

$BABY said that for FY18, the company expects revenue of $535-540MM and non-GAAP EPS of $1.60-1.65. For 1Q18, the company expects revenue of $125-127MM and non-GAAP EPS of $0.23-0.24. For 4Q17, $BABY expects to report revenue of approx. $131-132MM, while for FY17 revenue is expected to be $500.5-501.5MM.

$BABY {{ '2018-01-05T14:35:34+0000' | timeago}} • Announcement

$BABY appointed Leslie McDonnell as VP and General Manager of its Newborn Care Business Unit. McDonnell will report to CEO Jim Hawkins, and will be responsible for leading and expanding Natus' newborn care business. McDonnell is expected to join Natus on Feb. 12, 2018.

$BABY {{ '2018-01-05T14:07:05+0000' | timeago}} • Announcement

$BABY has named Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit. Ms. McDonnell will report to Jim Hawkins, CEO. She is expected to join $BABY on February 12, 2018.

$ZBH {{ '2017-12-19T14:31:26+0000' | timeago}} • Announcement

$ZBH appointed Bryan Hanson as President and CEO and a member of the BoD, effective Dec. 19, 2017. Daniel Florin, who has served as Interim CEO since July 11, 2017, will continue in his role as SVP and CFO. Most recently, Hanson served as a $MDT's Executive Committee member and as EVP and President of Medtronic's Minimally Invasive Therapies Group.

$MDT {{ '2017-12-19T14:11:39+0000' | timeago}} • Announcement

$MDT has named Bob White, previously SVP and President of APAC Region, as EVP and President of Minimally Invasive Therapies Group. The company also announced Chris Lee, SVP and President of Greater China Region, will assume the position of APAC Region President. These leadership changes are effective immediately.

$SYK {{ '2017-12-12T14:28:46+0000' | timeago}} • Announcement

$SYK said Howard Cox Jr. has notified the company that he will not stand for re-election at Stryker's 2018 Annual Meeting, which is expected to be held on May 2, 2018. In light of Cox's immense contributions to the company, he will be named Director Emeritus.

$HLS {{ '2017-12-12T13:23:46+0000' | timeago}} • Announcement

$HLS appointed Nancy Schlichting as an independent director, effective Dec. 11, 2017. With this appointment, the Board will expand to 11 directors. Schlichting currently serves on the boards of $WBA and $HRC.

$SYK {{ '2017-12-11T21:53:53+0000' | timeago}} • Announcement

$SYK said that the simplified public tender offer for the shares and BSAAR warrants of VEXIM has closed. $SYK, which already owned over 50% of the share capital and voting rights of VEXIM, acquired an additional 4.04MM shares during the offer period, as well as 226,520 BSAAR warrants that it has exercised for new shares of VEXIM.

$MDT {{ '2017-12-08T21:21:14+0000' | timeago}} • Announcement

$MDT BoD approved 3Q18 cash dividend of $0.46 per ordinary share, representing a 7% increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in June 2017.

$ENTL {{ '2017-12-08T17:39:22+0000' | timeago}} • Announcement

Rowley Law PLLC is investigating potential claims against $ENTL and its BoD for breach of fiduciary duty concerning the proposed acquisition of the company by $SYK. Stockholders will receive $24.00 in cash for each share of $ENTL that they hold. The transaction is valued at about $662MM.

$SYK {{ '2017-12-07T16:33:56+0000' | timeago}} • Announcement

$SYK agreed to buy $ENTL for $24 per share, or an equity value of about $662MM. The transaction is expected to be dilutive to $SYK's 2018 adjusted EPS by about $0.04 and accretive thereafter. Guggenheim Securities served as financial advisor and Skadden, Arps, Slate, Meagher & Flom LLP served as outside legal counsel for $SYK.

$VAR {{ '2017-12-07T15:05:38+0000' | timeago}} • Announcement

Medical devices maker $VAR said it received ANVISA registration for its cancer treatment device Halcyon in Brazil. The registration allows the company to market the new system in the Latin American country. Halcyon is designed to simplify operations and save time without compromising on quality.

$SYK {{ '2017-12-07T14:25:00+0000' | timeago}} • Announcement

$SYK BoD declared a quarterly dividend of $0.47 per share payable on January 31, 2018 to shareholders of record on December 29, 2017. This  represents an increase of approx. 11% compared to the prior year and the previous quarter.

$HRC {{ '2017-11-27T15:52:09+0000' | timeago}} • Announcement

IMRIS and $HRC said Hill-Rom's Trumpf Medical has completed device listing and registration with FDA for a new multi-functional operating room table specifically designed for the IMRIS Surgical Theatre. Full market launch is expected in early 2018.

$MDT {{ '2017-11-22T20:29:59+0000' | timeago}} • Webcast

In Oct., Animas announced to cease the manufacture and sale of its insulin pumps and partnered with $MDT to offer its customers the opportunity to transfer to a new device.With $JNJ exiting the insulin pump market in the US and Canada, $MDT now has access to the 90,000 patients who use Animas insulin pumps.

$MDT {{ '2017-11-22T20:27:57+0000' | timeago}} • Webcast

$MDT got US FDA approval for its MiniMed 670G hybrid closed-loop system and rolled the device out in a Priority Access program. It began shipping systems to patients in June. The company now expects growth to significantly improve in 3Q18 as it has finished shipping pumps for the program.

Recent Transcripts

MDT (Medtronic plc)
Tuesday, November 21 2017 - 1:00pm
ONVO (Organovo Holdings, Inc.)
Thursday, November 9 2017 - 10:00pm
TRXC (TransEnterix, Inc.)
Thursday, November 9 2017 - 9:30pm
RMTI (Rockwell Medical, Inc.)
Wednesday, November 8 2017 - 9:30pm
ELMD (Electromed, Inc.)
Wednesday, November 8 2017 - 2:00pm
TXMD (TherapeuticsMD, Inc.)
Monday, November 6 2017 - 1:00pm
HRC (Hill-Rom Holdings, Inc.)
Friday, November 3 2017 - 12:00pm
IRIX (IRIDEX Corporation)
Thursday, November 2 2017 - 9:00pm
SYN (Synthetic Biologics Inc.)
Wednesday, November 1 2017 - 8:30pm
MASI (Masimo Corporation)
Tuesday, October 31 2017 - 8:30pm
SYK (Stryker Corporation)
Thursday, October 26 2017 - 8:30pm
VAR (Varian Medical Systems, Inc.)
Wednesday, October 25 2017 - 9:00pm
BABY (Natus Medical Inc.)
Wednesday, October 25 2017 - 3:00pm
NURO (NeuroMetrix Inc.)
Thursday, October 19 2017 - 12:00pm
PTN (Palatin Technologies Inc.)
Monday, September 25 2017 - 3:00pm
ELMD (Electromed, Inc.)
Wednesday, September 6 2017 - 1:00pm
MDT (Medtronic plc)
Tuesday, August 22 2017 - 12:00pm
ONVO (Organovo Holdings, Inc.)
Wednesday, August 9 2017 - 9:00pm
RMTI (Rockwell Medical, Inc.)
Wednesday, August 9 2017 - 8:30pm
IRIX (IRIDEX Corporation)
Thursday, August 3 2017 - 9:00pm

AlphaGraphics you may like